At the first sign of a disease pandemic, public health officials should begin strongly communicating about the extent of the outbreak and the steps that can be taken by the public to avoid infection.
Read MoreCepheid announced that its Xpert MTB/RIF test was the subject of a study published in the latest edition of the New England Journal of Medicine (NEJM), “Rapid Molecular Detection of Tuberculosis and Rifampin Resistance.”
Read More
Inside this issue of CLP magazine, you’ll find our third annual respiratory virus supplement, which I hope you find useful as you prepare for the upcoming flu season. We are all breathing a bit easier now than we were at this time last y
Read More
MRSA is declining but still deadly, while other HIAs continue to grow in prevalence.
Read MoreAbbott announced it has received approval from the U.S. Food and Drug Administration (FDA) to market the Abbott RealTime HBV assay for measuring viral load or the amount of hepatitis B virus (HBV) in a patient’s blood.
Read More